^ abHashimoto M, Rockenstein E, Crews L, Masliah E (2003). “Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases”. Neuromolecular Med.4 (1-2): 21–36. doi:10.1385/NMM:4:1-2:21. PMID14528050.
^Tiraboschi P, Hansen L, Thal L, Corey-Bloom J (2004). “The importance of neuritic plaques and tangles to the development and evolution of AD.”. Neurology62 (11): 1984–9. PMID15184601.
^Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994). “Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital”. Cereb. Cortex4 (2): 138–50. doi:10.1093/cercor/4.2.138. PMID8038565.
^Kerr ML, Small DH (2005). “Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development”. J. Neurosci. Res.80 (2): 151–9. doi:10.1002/jnr.20408. PMID15672415.
^Danielsson J, Andersson A, Jarvet J, Gräslund A (2006). “15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length”. Magnetic resonance in chemistry : MRC44 Spec No: S114–21. doi:10.1002/mrc.1814. PMID16826550.
^Tomaselli S, Esposito V, Vangone P, et al. (2006). “The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding”. Chembiochem7 (2): 257–67. doi:10.1002/cbic.200500223. PMID16444756.
^Ohnishi S, Takano K (2004). “Amyloid fibrils from the viewpoint of protein folding”. Cell. Mol. Life Sci.61 (5): 511–24. doi:10.1007/s00018-003-3264-8. PMID15004691.
^Goedert M, Klug A, Crowther RA (2006). “Tau protein, the paired helical filament and Alzheimer's disease”. J. Alzheimers Dis.9 (3 Suppl): 195–207. PMID16914859.
^Pastorino L, Sun A, Lu PJ, et al. (2006). “The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production”. Nature440 (7083): 528–34. doi:10.1038/nature04543. PMID16554819.
^Shen ZX (2004). “Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease”. Med. Hypotheses63 (2): 308–21. doi:10.1016/j.mehy.2004.02.031. PMID15236795.
^Wenk GL (2003). “Neuropathologic changes in Alzheimer's disease”. The Journal of clinical psychiatry64 Suppl 9: 7–10. PMID12934968.
^Gray EG, Paula-Barbosa M, Roher A (1987). “Alzheimer's disease: paired helical filaments and cytomembranes”. Neuropathol. Appl. Neurobiol.13 (2): 91–110. doi:10.1111/j.1365-2990.1987.tb00174.x. PMID3614544.
^Williams DR (2006). “Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau”. Internal medicine journal36 (10): 652–60. doi:10.1111/j.1445-5994.2006.01153.x. PMID16958643.
^Nistor M, Don M, Parekh M, et al. (2007). “Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain”. Neurobiol. Aging28 (10): 1493–506. doi:10.1016/j.neurobiolaging.2006.06.023. PMID16904243.
^Gregory GC, Halliday GM (2005). “What is the dominant Abeta species in human brain tissue? A review”. Neurotoxicity research7 (1-2): 29–41. doi:10.1007/BF03033774. PMID15639796.
^Blanchard BJ, Hiniker AE, Lu CC, Margolin Y, Yu AS, Ingram VM (2000). “Elimination of Amyloid beta Neurotoxicity”. J Alzheimers Dis2 (2): 137–149. PMID12214104.
^Abramov AY, Canevari L, Duchen MR (2004). “Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture”. Biochim. Biophys. Acta1742 (1-3): 81–7. doi:10.1016/j.bbamcr.2004.09.006. PMID15590058.
^Barghorn S, Nimmrich V, Striebinger A, et al. (2005). “Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease”. J. Neurochem.95 (3): 834–47. doi:10.1111/j.1471-4159.2005.03407.x. PMID16135089.
^Kokubo H, Kayed R, Glabe CG, Yamaguchi H (2005). “Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain”. Brain Res.1031 (2): 222–8. doi:10.1016/j.brainres.2004.10.041. PMID15649447.
^Porat Y, Abramowitz A, Gazit E. (2006). Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67(1):27-37.
^Kanapathipillai M, Lentzen G, Sierks M, Park CB (2005). “Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid”. FEBS Lett.579 (21): 4775–80. doi:10.1016/j.febslet.2005.07.057. PMID16098972.
^Lee KH, Shin BH, Shin KJ, Kim DJ, Yu J (2005). “A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by beta-amyloid (1-42)”. Biochem. Biophys. Res. Commun.328 (4): 816–23. doi:10.1016/j.bbrc.2005.01.030. PMID15707952.
^Moreno, H.; Yu, E.; Pigino, G.; Hernandez, A. I.; Kim, N.; Moreira, J. E.; Sugimori, M.; Llinas, R. R. (2009). “Synaptic transmission block by presynaptic injection of oligomeric amyloid beta”. Proceedings of the National Academy of Sciences106 (14): 5901–5906. doi:10.1073/pnas.0900944106. ISSN0027-8424.
^Pigino, G.; Morfini, G.; Atagi, Y.; Deshpande, A.; Yu, C.; Jungbauer, L.; LaDu, M.; Busciglio, J. et al. (2009). “Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta”. Proceedings of the National Academy of Sciences106 (14): 5907–5912. doi:10.1073/pnas.0901229106. ISSN0027-8424.
^"Edlund C, Söderberg M, Kristensson K. Neurochem Int, 1994 Jul,25(1), 35-8."
Strategi Solo vs Squad di Free Fire: Cara Menang Mudah!